Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Hims & Hers Health Inc’s stock clocked out at $26.10, down -6.01% from its previous closing price of $27.77. In other words, the price has decreased by -$6.01 from its previous closing price. On the day, 26.68 million shares were traded.
Ratios:
To gain a deeper understanding of HIMS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 29.24. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 03 ’25 when Becklund Irene sold 2,203 shares for $28.78 per share. The transaction valued at 63,402 led to the insider holds 8,007 shares of the business.
Okupe Oluyemi sold 11,581 shares of HIMS for $338,833 on Apr 02 ’25. The Chief Financial Officer now owns 124,104 shares after completing the transaction at $29.26 per share. On Apr 03 ’25, another insider, Becklund Irene, who serves as the Officer of the company, bought 2,203 shares for $28.78 each.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 48.80, and their Forward P/E ratio for the next fiscal year is 30.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.93 while its Price-to-Book (P/B) ratio in mrq is 12.09.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -33.21%, while the 200-Day Moving Average is calculated to be -0.75%.
Shares Statistics:
A total of 212.46M shares are outstanding, with a floating share count of 181.98M. Insiders hold about 18.09% of the company’s shares, while institutions hold 73.74% stake in the company.
